Skip to main content
Premium Trial:

Request an Annual Quote

LGC SeraCare Seraseq ctDNA MRD Panel Mix

LGC Seracare has launched the Seraseq ctDNA MRD Panel Mix reference material designed for use in patient-derived cell-free DNA minimal residual disease next-generation sequencing assays. The product was developed by combining a diseased cell line, its SNP-matched normal cell line, and biosynthetic DNA variants of clinical utility and/or targeted therapeutics, the company noted. The reference material is offered as a purified mutation mix ready for sequencing library prep with no additional extraction or purification step, according to the company.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.